Navigation Links
Dr. Kent Bottles Named ICSI President
Date:6/2/2008

BLOOMINGTON, Minn., June 2 /PRNewswire/ -- Kent Bottles, MD, has been named president of the Institute for Clinical Systems Improvement (ICSI).

Dr. Bottles is a board-certified pathologist who specialized in surgical and cyto-pathology. He also has extensive experience in integrated healthcare delivery systems, research, academia, commercial laboratories, genomics, proteomics, and management of biotech start-up companies.

"Dr. Bottles' selection came after an extensive review of a slate of very strong candidates," said John Allen, MD, MBA, Minnesota Gastroenterology, and chair, ICSI board of directors. "He has unique knowledge about the major economic and quality issues facing medicine today. Plus he will bring an energy and dedication to advancing ICSI issues that will help transform medical care in Minnesota."

Bottles was vice president and chief medical officer of the 23-hospital Iowa Health System. Prior to that, he served as president and CEO of Grand Rapids Medical Education & Research Center for Health Professions, a multi-institutional consortium of health care organizations, and as president of Genomics Repository and chief knowledge officer, Geonomics Collaborative, Inc. Bottles also has extensive academic experience, including serving as Professor and Acting Head, Department of Pathology and Laboratory Medicine at the University of Iowa. He was also the founding medical director of managed care plans for University of Iowa employees.

A regular speaker and a prolific author, Bottles has addressed topics ranging from quality and patient safety and disruptive technology to patient-physician relationships and the future of medicine. He has received numerous honors, including the Rodney T. West Literary Achievement Award for the most important article on medical management presented by the American College of Physician Executives.

Bottles earned a medical degree from Case Western Reserve University in Ohio. He has broa
'/>"/>

SOURCE Institute for Clinical Systems Improvement
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bounty Poll Reveals British Mums in the Dark Over Bisphenol-A in Baby Bottles
2. Playtex(R) Offers Free Non-BPA Baby Bottles to Parents, Will Stop Using BPA in All Products This Year
3. Wal-Mart & Nalgene Removing Toxic Bottles, Place Consumers Concerns First
4. Juvenile Products Manufacturers Association Supports Safety of Baby Bottles
5. CamelBak(R) CEO Statement on BPA and Plastic Re-Usable Water Bottles
6. Report Shows Dangerous Chemical Can Leach From Baby Bottles
7. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
8. JPMA on the Safety of Baby Bottles
9. Heating Plastic Bottles Releases Potentially Harmful Chemical
10. Hot liquids release potentially harmful chemicals in polycarbonate plastic bottles
11. Jacobs-Wagner named Howard Hughes Investigator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Accountable care organizations (ACOs) are increasingly partnering ... worries that these product types were too similar to ... that product-based ACOs will continue to grow in size ... June issue of Atlantic Information Services, Inc.’s (AIS) AIS’s ... that the backlash from HMOs seems to be fading ...
(Date:6/3/2015)... Save On Medical ( http://www.saveonmedical.com ) ... shopping for health care procedures easier for patients on ... look and makes it easier to compare the prices ... , Now, when patients search for the procedure they ... they can see the provider’s price and Docometer quality ...
(Date:6/3/2015)... The National Resident Matching Program Board of Directors ... of Medical Education at the University of California, San Diego ... , “It is an honor to assume the ... Dr. Savoia. “NRMP’s goal is to provide a fair, ... programs, and I welcome the opportunity to guide the organization ...
(Date:6/3/2015)... 2015 Dr. Steven Reisman, a nationally recognized ... ( http://www.newyorkcardiac.com ) located in NYC, announced today the expansion ... practice. In most cases, depending on the level of care ... call, they will be seen by a cardiologist that same ... cardiologist is to ensure that people who have an urgent ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 A ... will be honored with a Global Inspire Award at ... recognizes the organization’s outstanding volunteers for their leadership, level ... scale. , The recipients of the Author(s) ... group of authors whose article has made a significant ...
Breaking Medicine News(10 mins):Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 3Health News:Save On Medical Launches New Mobile-Optimized Website 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4
... as eunuchs, can now choose a gender of their liking ... //to a special procedure developed at the All India Institute ... 1,100 patients have already given proper gender identities as males ... life, doctors at the premier research and referral institute said. ...
... looking at lactate with a much more positive eye, ... in the immediate //hours after a traumatic brain injury ... right, it could change how emergency room physicians and ... the first critical hours after injury. ,Previous ...
... technology that can quickly screen all 20,000-plus human genes for ... affect how sensitive human cancer cells are to certain chemotherapy ... in the April 12 edition of the journal Nature, researchers ... library of small RNA molecules – the first used by ...
... With allergy season in full bloom, the American Academy of ... of what you can do to cope with the pollen ... specialist can help. // ,This spring, pollen from blooming ... 45 million Americans, causing itching eyes, sneezing, nasal stuffiness, nasal ...
... in erectile dysfunction, decreased libido, anemia, sarcopenia, memory loss, ... ,While a low serum testosterone level is well-known for ... overall physical functioning and fall risk has not been ... of the Archives of Internal Medicine, Orwoll and colleagues ...
... of Queensland men have never been screened for prostate, colorectal ... ,Screening for colorectal cancer currently has stronger scientific evidence for ... skin cancer, but a new study in the Medical Journal ... colorectal cancer test than the other two. ...
Cached Medicine News:Health News:New Procedure Paves Way for Eunuchs to Choose a Gender and Conceive 2Health News:Study Challenges Conventional Treatment of Traumatic Brain Injury 2Health News:Gene Screening Points Way to More Effective Chemotherapy 2Health News:April Showers Bring May Flowers – And Plenty of Pollen, To 2Health News:Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men 2
(Date:6/3/2015)... -- The North American spine surgery devices market is ... U.S. having the maximum market share. This region is ... The market, by product type, encompasses spinal ... devices, non-fusion implant devices, and spine bone stimulators devices. ... is the largest and fastest-growing segment. Key players ...
(Date:6/3/2015)...  Actavis plc (NYSE: ACT ), a leading global ... and President of Actavis, will provide an overview and update ... Global Healthcare Conference in Rancho Palos Verdes, Calif. ... The presentation will take place on Wednesday, June ... Resort, Rancho Palos Verdes, Calif.  To ...
(Date:6/3/2015)... , June 02, 2015 Research ... addition of the "The Future of Pharmaceutical ... As they are in a desperate need to ... low cost, drug companies have been increasingly utilizing ... their productivity while constantly streamlining their internal operation. ...
Breaking Medicine Technology:Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2The Future of Pharmaceutical Outsourcing: 2015 Report 2
... MOUNTAIN VIEW, Calif. , Jan. 28 Omnicell, Inc. (Nasdaq: ... facilities, today announced results for its fourth quarter and year ended ... fourth quarter of 2009 was $54.7 million , up $0.7 ... $7.4 million or 11.9% from the fourth quarter of 2008. ...
... , SAN DIEGO , Jan. 28 ... Phase II clinical trial evaluating CTS-1027 in combination with pegylated ... activity, safety and tolerability of the triple combination will be ... is a significant unmet medical need in HCV patients who ...
Cached Medicine Technology:Omnicell Announces Fourth Quarter and Full-Year 2009 Results 2Omnicell Announces Fourth Quarter and Full-Year 2009 Results 3Omnicell Announces Fourth Quarter and Full-Year 2009 Results 4Omnicell Announces Fourth Quarter and Full-Year 2009 Results 5Omnicell Announces Fourth Quarter and Full-Year 2009 Results 6Omnicell Announces Fourth Quarter and Full-Year 2009 Results 7Omnicell Announces Fourth Quarter and Full-Year 2009 Results 8Omnicell Announces Fourth Quarter and Full-Year 2009 Results 9Omnicell Announces Fourth Quarter and Full-Year 2009 Results 10Omnicell Announces Fourth Quarter and Full-Year 2009 Results 11Omnicell Announces Fourth Quarter and Full-Year 2009 Results 12Omnicell Announces Fourth Quarter and Full-Year 2009 Results 13Omnicell Announces Fourth Quarter and Full-Year 2009 Results 14Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) 2Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) 3
... IgG Test is an ELISA ... of IgG to Varicella Zoster ... used as,an aid to determine ... status may be determined using ...
The ImmunoWELL Thyroglobulin IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroglobulin in serum and is used as an aid ...
... Screening Panel 4 is an enzyme ... detection of autoantibodies against various specific ... and Sm) in serum, and is ... diagnosis of systemic lupus erythematosus (SLE), ...
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Medicine Products: